BLNC
Balance Labs, Inc.1.5500
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
72.62MP/E (TTM)
-Basic EPS (TTM)
-0.17Dividend Yield
0%Recent Filings
8-K
10-Q
8-K
Balance Labs names new CEO
Balance Labs appointed Alan Campbell as CEO on August 25, 2025, replacing Michael D. Farkas, who remains Chairman and President. Campbell, with deep experience scaling index businesses at CoinDesk and Bloomberg, steps in to drive the company's digital asset strategy. His deal includes a $350,000 base salary post-capital raise, 65% target bonus, and 3.6% equity vesting over three years. Leadership shift bolsters expertise, yet ties pay to funding success.
10-Q
Q2 FY2025 results
Balance Labs posted a narrower net loss of $152,548 for the six months ended June 30, 2025, down 30% y/y from $217,643, thanks to a $127,579 gain on settling old accounts payable that offset higher professional fees up 111% to $51,716 and an $8,769 unrealized loss on marketable securities. Operating loss widened to $158,098, up 28% y/y (derived), driven by elevated legal and accounting costs, while the net loss narrowed as other income turned positive at $5,550 versus $94,054 expense last year; the gap stems mainly from interest expense of $113,260 and the settlement gain. Cash dwindled to $3,625 from $13,199 at year-end after $57,574 used in operations, propped by $48,000 in related-party advances amid $5.3M liabilities including $525,000 convertible notes in default. No free cash flow disclosed in the 10-Q. Substantial doubt lingers on going concern viability.
10-Q
Q1 FY2025 results
Balance Labs posted a slim $6,406 net loss for Q1 FY2025 ended March 31, 2025, a sharp 95% improvement from $116,943 a year earlier, thanks to a $127,579 gain on settling old accounts payable that offset $78,839 in operating expenses—up 20% y/y from $65,718 amid higher professional fees. No revenue yet, but marketable securities ticked up $1,594 in unrealized gains, while interest expense held steady at $56,740. Cash dipped to $3,040 from $13,199 q/q after $22,659 in operating outflows, propped by $12,500 in related-party advances; total debt lingers at $5.2M, mostly related-party notes in default. No free cash flow disclosed in the 10-Q. Subsequent CEO loans added $30,500 in April-May. Yet liquidity strains persist.
AERT
Aeries Technology, Inc.
0.57-0.01
BLND
Blend Labs, Inc.
3.04+0.01
CRAI
CRA International,Inc.
202.19+3.00
HURN
Huron Consulting Group Inc.
179.14+0.74
LAWR
Robot Consulting Co., Ltd.
3.75+0.00
LH
Labcorp Holdings Inc.
258.11-5.22
NORD
Nordicus Partners Corp.
4.95+0.20
SSHT
SSHT S&T Group Ltd.
0.04-0.01
XYLB
XY LABS INC
0.16+0.00
ZGM
Zenta Group Company Limited
2.39-0.10